Zydus inks licensing agreement with Daewoong Pharmaceutical for leuprolide injectable in the US
The exclusive agreement also includes development, regulatory, and commercialization milestone payments based on the successful outcome
The exclusive agreement also includes development, regulatory, and commercialization milestone payments based on the successful outcome
The license agreement grants Dr. Reddy's the exclusive rights to commercialize the proposed biosimilar in select countries in Latin America and Southeast Asia
Subscribe To Our Newsletter & Stay Updated